Maternal asthma symptom frequency in early adulthood and its association with offspring health
Pediatric Allergy and Immunology · 2026-11 · 37 (11)
DOI: 10.1111/pai.70547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 09.11.2026. Verfasst von Nai-Yun Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mater Research Institute, the University of Queensland, Brisbane, Australia. Hauptthemen laut MEDLINE: Asthma, Prenatal Exposure Delayed Effects. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Australian Government Department of Health, Disability and Ageing, National Health and Medical Research Council (NHMRC), Department of Health, Disability and Ageing.
Abstract (Originalsprache)
Background
Little is known about whether increasing maternal asthma symptom frequency is associated with adverse childhood health outcomes beyond respiratory and allergic diseases.
Methods
Data were obtained from a prospective cohort of 3033 mothers and 5768 children in the Australian Longitudinal Study on Women's Health (ALSWH) and the Mothers and their Children's Health (MatCH) substudy. Maternal self‐reported asthma symptom frequency was classified as never, rarely, sometimes, or often (18–23 years). Childhood health outcomes were maternally reported (mean age 7 years). Models accounted for sibling clustering, were adjusted for maternal and child characteristics, and interactions by child sex were assessed.
Results
Graded associations were observed between maternal asthma symptom frequency and multiple offspring outcomes. The largest effects were for childhood asthma (aOR 3.11, 95% CI 2.16–4.48), chest infections (2.50, 1.82–3.44), parent‐reported anxiety (2.37, 1.62–3.48), respiratory allergy (2.21, 1.54–3.15), non‐food allergy (2.04, 1.33–3.12), and food intolerance (2.03, 1.28–3.20) among children of mothers reporting asthma symptoms often. Graded relationships were also evident for food allergy and eczema. No robust evidence of effect modification by child sex was observed.
Conclusion
Asthma symptom frequency in young women may have long‐term implications for the health of their future children. These findings underscore the importance of optimizing asthma management before and throughout the reproductive years. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mater Research Institute, the University of Queensland, Brisbane, Australia.
- Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
- School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia.
- The Children's Health and Environment Program, Child Health Research Centre, The University of Queensland, Brisbane, Australia.
- Queensland Paediatric Immunology and Allergy Service, Queensland Children's Hospital, South Brisbane, Australia.
ORCID-Profile: Nai-Yun Hsu, Michael Waller, Leigh Tooth, Peter D Sly, Vicki L Clifton
Förderung
- Australian Government Department of Health, Disability and Ageing
- National Health and Medical Research Council (NHMRC)
- Department of Health, Disability and Ageing
Zitieren
APA
Hsu, N. Y., Pelecanos, A., Waller, M., Tooth, L., Sly, P. D., Peake, J., & Clifton, V. L. (2026). Maternal asthma symptom frequency in early adulthood and its association with offspring health. Pediatric Allergy and Immunology, 37(11). https://doi.org/10.1111/pai.70547
Vancouver
Hsu NY, Pelecanos A, Waller M, Tooth L, Sly PD, Peake J, et al. Maternal asthma symptom frequency in early adulthood and its association with offspring health. Pediatric Allergy and Immunology. 2026;37(11). doi:10.1111/pai.70547
BibTeX
@article{Hsu2026,
author = {Hsu, Nai-Yun and Pelecanos, Anita and Waller, Michael and Tooth, Leigh and Sly, Peter D and Peake, Jane and Clifton, Vicki L},
title = {Maternal asthma symptom frequency in early adulthood and its association with offspring health},
journal = {Pediatric Allergy and Immunology},
year = {2026},
volume = {37},
number = {11},
doi = {10.1111/pai.70547}
}
EUVIMED